Mustafa Bisher O, Rathbun Suman W, Whitsett Thomas L, Raskob Gary E
Department of Medicine, Room WP 3120, The University of Oklahoma Health Sciences Center, 920 Stanton L. Young Blvd, Oklahoma City, OK 73104, USA.
Arch Intern Med. 2002 Feb 25;162(4):401-4. doi: 10.1001/archinte.162.4.401.
To determine the sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis and to determine the safety of withholding anticoagulant therapy in patients with negative ultrasonographic results.
The MEDLINE database was searched for literature published from January 1, 1980, to December 31, 2000, that evaluated ultrasonography for the diagnosis of upper extremity deep vein thrombosis. Bibliographies of the retrieved articles were cross-checked to identify additional studies.
All prospective English-language studies were selected. Retrospective studies, review articles, and case reports were excluded.
Two of us (B.O.M. and S.W.R.) used predefined criteria to independently assess each study. Data on sensitivity and specificity and the associated 95% confidence intervals were recorded when available.
Only one study met all of the predefined criteria for adequately evaluating sensitivity and specificity. The sensitivity of duplex ultrasonography ranged from 56% to 100%, and the specificity ranged from 94% to 100%. No study evaluated the safety of withholding anticoagulant therapy without additional testing in patients with negative ultrasonographic results.
The safety of withholding anticoagulant treatment in a patient with suspected upper extremity deep vein thrombosis and negative ultrasonographic results is uncertain.
确定超声检查在上肢深静脉血栓形成诊断中的敏感性和特异性,并确定超声检查结果为阴性的患者停用抗凝治疗的安全性。
检索MEDLINE数据库中1980年1月1日至2000年12月31日发表的评估超声检查诊断上肢深静脉血栓形成的文献。对检索到的文章的参考文献进行交叉核对以识别其他研究。
选择所有前瞻性英文研究。排除回顾性研究、综述文章和病例报告。
我们两人(B.O.M.和S.W.R.)使用预先定义的标准独立评估每项研究。如有可用数据,记录敏感性、特异性及相关的95%置信区间。
只有一项研究符合充分评估敏感性和特异性的所有预先定义标准。双功超声检查的敏感性范围为56%至100%,特异性范围为94%至100%。没有研究评估超声检查结果为阴性的患者在不进行额外检查的情况下停用抗凝治疗的安全性。
对于疑似上肢深静脉血栓形成且超声检查结果为阴性的患者,停用抗凝治疗的安全性尚不确定。